Expertise in
13
conditions

Dr. Jay Traverse

Interventional Cardiology
Vascular Specialists Of Minnesota
920 E 28th St Ste 300, 
Minneapolis, MN 
Expertise in
13
conditions
Vascular Specialists Of Minnesota
920 E 28th St Ste 300, 
Minneapolis, MN 

Overview

Jay Traverse is an Interventional Cardiologist in Minneapolis, Minnesota. Dr. Traverse is highly rated in 13 conditions, according to our data. His top areas of expertise are Angina, Heart Attack, Coronary Heart Disease, Bone Marrow Aspiration, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 119 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Interventional Cardiology

Licenses

Internal Medicine in MN

Hospital Affiliations

Glencoe Regional Health
New Ulm Medical Center
Ridgeview Medical Center
Abbott Northwestern Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Sanford Health
  • HMO
  • PPO
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Vascular Specialists of Minnesota
920 E 28th St Ste 300, Minneapolis, MN 55407
Other Locations
West Central Internal Medicine
24 E 7th St, Morris, MN 56267

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase 1 Open Label, Dose Escalation Trial of Intracoronary Infusion of AB-1002 in Subjects With NYHA Class III Heart Failure
Phase 1 Open Label, Dose Escalation Trial of Intracoronary Infusion of AB-1002 in Subjects With NYHA Class III Heart Failure
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2025
Intervention Type: Biological
Study Drug: 3 x 10e13vg NAN-101
Study Phase: Phase 1
Myocardial Ischemia and Transfusion
Myocardial Ischemia and Transfusion
Enrollment Status: Completed
Publish Date: May 09, 2024
Intervention Type: Biological
Study Phase: Phase 3
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
A Phase 1/2 Trial of Direct Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector Expressing a cDNA/Genomic Hybrid of Human VEGF, to the Ischemic Myocardium of Subjects With Angina Pectoris
A Phase 1/2 Trial of Direct Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector Expressing a cDNA/Genomic Hybrid of Human VEGF, to the Ischemic Myocardium of Subjects With Angina Pectoris
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Biological
Study Drug: Replication-Deficient Adenovirus Vector-Expressing cDNA/Genomic Hybrid VEGF
Study Phase: Phase 1/Phase 2
A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 in Subjects With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 in Subjects With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
Enrollment Status: Terminated
Publish Date: October 17, 2023
Intervention Type: Biological
Study Drug: CLBS16 Granulocyte Colony-Stimulating Factor-Mobilized Autologous CD34-Positive Cells
Study Phase: Phase 2
A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, & Efficacy of Autologous Mesenchymal Stem Cells & C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic HF
A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, & Efficacy of Autologous Mesenchymal Stem Cells & C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic HF
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Biological
Study Phase: Phase 2
A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy
A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy
Enrollment Status: Completed
Publish Date: November 05, 2020
Intervention Type: Biological
Study Phase: Phase 1
View 6 Less Clinical Trials

119 Total Publications

Association Between Artificial Intelligence Detected Features on the ECG and Presence of Microvascular Obstruction.
Association Between Artificial Intelligence Detected Features on the ECG and Presence of Microvascular Obstruction.
Journal: Circulation. Cardiovascular interventions
Published: November 10, 2025
Similar Doctors
Expertise in
12
conditions
Dr. Demetris Yannopoulos
Interventional Cardiology
Expertise in
12
conditions
Dr. Demetris Yannopoulos
Interventional Cardiology

University Of Minnesota Masonic Children's Hospital

420 Delaware St SE, 
Minneapolis, MN 
 (76.2 miles away)
612-625-4465
Languages Spoken:
English
See accepted insurances

Demetris Yannopoulos is an Interventional Cardiologist in Minneapolis, Minnesota. Dr. Yannopoulos is highly rated in 12 conditions, according to our data. His top areas of expertise are Ventricular Fibrillation, Cardiac Arrest, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Expertise in
15
conditions
Dr. Jeffrey Chambers
Interventional Cardiology
Expertise in
15
conditions
Dr. Jeffrey Chambers
Interventional Cardiology

Office

4040 Coon Rapids Blvd NW Ste 120, 
Minneapolis, MN 
 (81.1 miles away)
763-427-9980
Languages Spoken:
English
See accepted insurances

Jeffrey Chambers is an Interventional Cardiologist in Minneapolis, Minnesota. Dr. Chambers is highly rated in 15 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Heart Attack, Angina, Atherectomy, and Angioplasty.

Expertise in
15
conditions
Dr. Ganesh Raveendran
Interventional Cardiology
Expertise in
15
conditions
Dr. Ganesh Raveendran
Interventional Cardiology

U Of M Health Clinics And Surgery Center Inc.

909 Fulton St SE, 
Minneapolis, MN 
 (76.5 miles away)
612-365-5000
Languages Spoken:
English
See accepted insurances

Ganesh Raveendran is an Interventional Cardiologist in Minneapolis, Minnesota. Dr. Raveendran is highly rated in 15 conditions, according to our data. His top areas of expertise are Ventricular Fibrillation, Aortic Valve Stenosis, Cardiac Arrest, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Frequently Asked Questions about Dr. Jay Traverse

How do I make an appointment with Dr. Jay Traverse?

You can book an appointment with Dr. Jay Traverse by calling their office at 612-863-3900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jay Traverse a top-rated expert for Bone Marrow Aspiration?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jay Traverse is classified as an Elite expert for Bone Marrow Aspiration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jay Traverse specialize in?

While Dr. Jay Traverse is a Interventional Cardiology, they have specific expertise in Bone Marrow Aspiration, Angina, and Heart Attack. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Interventional Cardiology.

Does Dr. Jay Traverse participate in research or clinical trials?

Yes. Dr. Jay Traverse has published 119 articles and abstracts on conditions like Bone Marrow Aspiration. You can view a list of Dr. Jay Traverse's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jay Traverse accept my insurance?

Dr. Jay Traverse accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 612-863-3900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Traverse's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 35 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile